Change in Management

Ref: Akums/Exchange/2026-27/57 October 31, 2026 To, To, The Listing Department The Listing Department National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, C-1, Block G, 25th Floor, New Trading Ring, Bandra Kurla Complex, Rotunda Building, Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai – 400 051 Dalal Street, Mumbai – 400 001 Symbol: AKUMS Scrip Code: 544222 Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Cessation of Mr. Sunil Jaiswal as Senior Management Personnel Respected Sir/Ma’am, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”), this is to inform you that Mr. Sunil Jaiswal, Senior Vice President – Research & Development, Akums Drugs and Pharmaceuticals Limited (“the Company”) also designated as Senior Management Personnel of the Company, has resigned from his position due to some family commitments, Mr. Jaiswal has attained the age of 61 years. Mr. Jaiswal has submitted his resignation on 5th August 2026 with a request to relieve him from his duties w.e.f. October 30, 2026. Though, post discussion October 31, 2026 was agreed as his relieving date. Details to be provided, pursuant to SEBI LODR Regulations read with the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are enclosed herewith as Annexure-A and a copy of the resignation letter is also enclosed as Annexure - B. This is for your kind information and records. Thanking You Yours Faithfully For Akums Drugs and Pharmaceuticals Limited Dharamvir Malik Company Secretary & Compliance Officer Encl.: As above Annexure – A Details to be provided pursuant to Regulation 30 of SEBI LODR Regulations read with SEBI Master Circular vide No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026: Sr. Particulars Details 1. reason for change viz. Resignation of Mr. Sunil Jaiswal, Senior Vice appointment, re-appointment, President – Research & Development, designated resignation, removal, death or a s Senior Management Personnel of the Company otherwise; 2. date of appointment/re- October 31, 2026 appointment/cessation (as applicable) & term of appointment/re-appointment; 3. brief profile (in case of Not Applicable appointment); 4. disclosure of relationships Not Applicable between directors (in case of appointment of a director). Annexure - B